XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Numerator
Net increase (decrease) in net assets resulting from operations$119,685 $68,711 $248,909 $201,527 
Less: Total distributions declared(85,388)(77,943)(249,855)(231,868)
Total Earnings (loss), net of total distributions34,297 (9,232)(946)(30,341)
Earnings (loss), net of distributions attributable to common shares34,042 (9,232)(947)(30,341)
Add: Distributions declared attributable to common shares84,752 77,263 247,749 229,650 
Numerator for basic change in net assets per common share118,794 68,031 246,802 199,309 
Add: Income impact of assumed conversion of 2028 Convertible Notes4,1169,096 
Numerator for diluted change in net assets per common share$122,910 $68,031 $255,898 $199,309 
Denominator
Basic weighted average common shares outstanding180,360161,019175,633159,742
Incremental shares from assumed conversion of 2028 Convertible Notes13,38710,015
Common shares issuable611496603511
Weighted average common shares outstanding assuming dilution194,358161,515186,251160,253
Change in net assets per common share:
Basic$0.66 $0.42 $1.41 $1.25 
Diluted$0.63 $0.42 $1.37 $1.24 
Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and nine months ended September 30, 2025 and 2024, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Anti-dilutive Securities2025202420252024
Unvested common stock options1,5278321,2171,212
Unvested restricted stock awards— 1521,094398